| 8258151 |
3-aminoimidazo [1,2-A] pyridine derivatives as SGLT inhibitors |
Werner Mederski, Norbert Beier, Rolf Gericke, Markus Klein, Christos Tsaklakidis |
2012-09-04 |
$86,094,000 |
| 8153649 |
3-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the treatment of type 1 and type 2 diabetes |
Markus Klein, Rolf Gericke, Norbert Beier, Christos Tsaklakidis, Werner Mederski |
2012-04-10 |
$132,429,000 |
| 8129373 |
Carbonyl compounds |
Christos Tsaklakidis, Dieter Dorsch, Werner Mederski, Johannes Gleitz |
2012-03-06 |
$53,485,000 |
| 8119675 |
Benzimidazole derivatives |
Lars Burgdorf, Markus Klein, Rolf Gericke, Christos Tsaklakidis, Werner Mederski +1 more |
2012-02-21 |
$50,558,000 |
| 8093240 |
Triazole derivatives |
Christiane Amendt, Hartmut Greiner, Ulrich Graedler, Guenter Hoelzemann |
2012-01-10 |
$110,410,000 |
| 7977343 |
Adenine derivatives |
Hans-Peter Buchstaller, Hans-Michael Eggenweiler, Michael Wolf |
2011-07-12 |
$141,268,000 |
| 7951804 |
Piperidinyl compounds |
Dieter Dorsch, Werner Mederski, Christos Tsaklakidis, Johannes Gleitz |
2011-05-31 |
$84,401,000 |
| 7906516 |
Carbonyl compounds |
Christos Tsaklakidis, Dieter Dorsch, Werner Mederski, Johannes Gleitz |
2011-03-15 |
$44,210,000 |
| 7902223 |
Phenyl derivatives as factor XA inhibitors |
Dieter Dorsch, Christos Tsaklakidis, Werner Mederski, Johannes Gleitz, Christopher Barnes |
2011-03-08 |
$88,677,000 |
| 7763611 |
Aroylsemicarbazide derivatives against thromboembolic diseases |
Werner Mederski, Christos Tsaklakidis, Dieter Dorsch, Johannes Gleitz |
2010-07-27 |
$110,666,000 |
| 7732481 |
Prolinylarylacetamides |
Werner Mederski, Christos Tsaklakidis, Dieter Dorsch, Johannes Gleitz |
2010-06-08 |
$47,115,000 |
| 7687624 |
Process for the production of N-arylmorpholinones |
Dieter Dorsch, Werner Mederski, Christos Tsaklakidis, Hanns Wurziger |
2010-03-30 |
$119,966,000 |
| 7683093 |
Prolinyl derivatives for the treatment of thrombosis |
Werner Mederski, Christos Tsaklakidis, Dieter Dorsch, Johannes Gleitz |
2010-03-23 |
$104,659,000 |
| 7598241 |
Carboxamide derivatives and their use as factor Xa inhibitors |
Dieter Dorsch, Werner Mederski, Christos Tsaklakidis, Johannes Gleitz, Christoph van Amsterdam |
2009-10-06 |
$46,778,000 |
| 7579346 |
Carboxamides |
Dieter Dorsch, Werner Mederski, Christos Tsaklakidis, Hanns Wurziger, Johannes Gleitz +1 more |
2009-08-25 |
$66,463,000 |
| 7566789 |
Benzimidazole derivatives |
Dieter Dorsch, Wrner Mederski, Christos Tsaklakidis, Johannes Gleitz, Christopher Barnes |
2009-07-28 |
$106,879,000 |
| 7557222 |
1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis |
Werner Mederski, Christos Tsaklakidis, Dieter Dorsch, Johannes Gleitz |
2009-07-07 |
$88,433,000 |
| 7557102 |
Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor Xa inhibitors for the treatment of thromboses |
Werner Mederski, Christos Tsaklakidis, Dieter Dorsch, Johannes Gleitz |
2009-07-07 |
$88,433,000 |
| 7504500 |
Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products |
Werner Mederski, Christos Tsaklakidis, Dieter Dorsch, Johannes Gleitz |
2009-03-17 |
$70,771,000 |
| 7427618 |
Ethynyl derivatives as factor Xa inhibitors |
Werner Mederski, Christos Tsaklakidis, Dieter Dorsch, Johannes Gleitz, Christoph van Amsterdam |
2008-09-23 |
$142,456,000 |
| 7273867 |
Phenyl derivatives |
Dieter Dorsch, Werner Mederski, Christos Tsaklakidis, Johannes Gleitz, Christopher Barnes |
2007-09-25 |
$124,059,000 |
| 7199133 |
Derivatives of phenoxy-n-′4-(isothiazolindin-1, 1-dioxid-2yl)phenyll-valerian-acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors |
Dieter Dorsch, Christos Tsaklakidis, Werner Mederski, Johannes Gleitz, Christopher Barnes |
2007-04-03 |
$51,895,000 |
| 7183277 |
Carboxylic acid amides |
Dieter Dorsch, Werner Mederski, Johannes Gleitz, Christos Tsaklakidis, Christopher Barnes |
2007-02-27 |
$54,262,000 |
| 6943179 |
Biurethane derivatives |
Werner Mederski, Dieter Dorsch, Christos Tsaklakidis, Johannes Gleitz, Christopher Barnes |
2005-09-13 |
$99,640,000 |
| 6441013 |
Sulphonyloxazolamines as therapeutic active ingredients |
Hartmut Greiner, Gerd Bartoszyk, Henning Bottcher, Gerhard Barnickel |
2002-08-27 |
$72,946,000 |
